載入...
CSIG-20. INHIBITION OF AKT/SURVIVIN AND AKT/ID3 PATHWAYS BY CELECOXIB, A SELECTIVE COX-2 INHIBITOR, MAY HAVE PROMISING THERAPEUTIC POTENTIAL IN LOW-GRADE GLIOMA
Approximately half of the patients with low-grade glioma (LGG) treated surgically suffer recurrence or metastasis. Malignant transformation sometimes occurs after several years and no effective drug treatment has been established yet. Though the selective COX-2 inhibitor celecoxib showed anti-tumor...
Na minha lista:
發表在: | Neuro Oncol |
---|---|
Main Authors: | , , , , , , , , |
格式: | Artigo |
語言: | Inglês |
出版: |
Oxford University Press
2017
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5691934/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.214 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|